Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel PARP inhibitors prepared and tested at Pfizer

Feb. 4, 2004

Department of Defense award for vaccine technology development at Generex

Feb. 3, 2004

Photodynamic therapy in combination with DMXAA shows promising therapeutic advantages

Feb. 3, 2004

Pfizer team presents novel GnRH antagonists in a recent patent

Feb. 3, 2004

Merck presents novel KSP inhibitors with utility in cancer therapy

Feb. 3, 2004

Cerus acquires mesothelin rights from Johns Hopkins University

Feb. 2, 2004

New phase I trial for RSR-13 in locally advanced NSCLC

Feb. 2, 2004

Bevacizumab inhibits tumor vascularity

Feb. 2, 2004

Exelixis scientists present new antiangiogenic ADAM-10 inhibitors

Feb. 2, 2004

Antitumor effects reported for erlotinib in metastatic head and neck cancer

Feb. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...